1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Valganciclovir Market
2.2. Global Valganciclovir Market, By Patient Age Group, 2023 (US$ Million)
2.3. Global Valganciclovir Market, By Application, 2023 (US$ Million)
2.4. Global Valganciclovir Market, By Distribution Channel, 2023 (US$ Million)
2.5. Global Valganciclovir Market, By Geography, 2023 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2023
3. Valganciclovir Market: Competitive Analysis
3.1. Market Positioning of Key Valganciclovir Market Vendors
3.2. Strategies Adopted by Valganciclovir Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032
4. Valganciclovir Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Valganciclovir Market Value, 2022-2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Adult Patients
5.3.2. Pediatric Patients
6. Valganciclovir Market: By Application, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Organ Transplant
6.3.2. Cytomegalovirus Retinitis
7. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Hospitals Pharmacies
7.3.2. Retail Pharmacies
8. North America Valganciclovir Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
8.3. Valganciclovir Market: By Application, 2022-2032, USD (Million)
8.4. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
8.5. Valganciclovir Market: By Region, 2022-2032, USD (Million)
8.5.1. North America
8.5.1.1. U.S.
8.5.1.1.1. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
8.5.1.1.2. Valganciclovir Market: By Application, 2022-2032, USD (Million)
8.5.1.1.3. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
8.5.1.2.2. Valganciclovir Market: By Application, 2022-2032, USD (Million)
8.5.1.2.3. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
8.5.1.3.2. Valganciclovir Market: By Application, 2022-2032, USD (Million)
8.5.1.3.3. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
9. UK and European Union Valganciclovir Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
9.3. Valganciclovir Market: By Application, 2022-2032, USD (Million)
9.4. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
9.5. Valganciclovir Market: By Region, 2022-2032, USD (Million)
9.5.1. UK and European Union
9.5.1.1. UK
9.5.1.1.1. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
9.5.1.1.2. Valganciclovir Market: By Application, 2022-2032, USD (Million)
9.5.1.1.3. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
9.5.1.2.2. Valganciclovir Market: By Application, 2022-2032, USD (Million)
9.5.1.2.3. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
9.5.1.3.2. Valganciclovir Market: By Application, 2022-2032, USD (Million)
9.5.1.3.3. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
9.5.1.4.2. Valganciclovir Market: By Application, 2022-2032, USD (Million)
9.5.1.4.3. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
9.5.1.5. France
9.5.1.5.1. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
9.5.1.5.2. Valganciclovir Market: By Application, 2022-2032, USD (Million)
9.5.1.5.3. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
9.5.1.6.2. Valganciclovir Market: By Application, 2022-2032, USD (Million)
9.5.1.6.3. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
10. Asia-Pacific Valganciclovir Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
10.3. Valganciclovir Market: By Application, 2022-2032, USD (Million)
10.4. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
10.5. Valganciclovir Market: By Region, 2022-2032, USD (Million)
10.5.1. Asia-Pacific
10.5.1.1. China
10.5.1.1.1. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
10.5.1.1.2. Valganciclovir Market: By Application, 2022-2032, USD (Million)
10.5.1.1.3. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
10.5.1.2.2. Valganciclovir Market: By Application, 2022-2032, USD (Million)
10.5.1.2.3. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
10.5.1.3. India
10.5.1.3.1. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
10.5.1.3.2. Valganciclovir Market: By Application, 2022-2032, USD (Million)
10.5.1.3.3. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
10.5.1.4.2. Valganciclovir Market: By Application, 2022-2032, USD (Million)
10.5.1.4.3. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
10.5.1.5.2. Valganciclovir Market: By Application, 2022-2032, USD (Million)
10.5.1.5.3. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
10.5.1.6. Rest of Asia-Pacific
10.5.1.6.1. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
10.5.1.6.2. Valganciclovir Market: By Application, 2022-2032, USD (Million)
10.5.1.6.3. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
11. Latin America Valganciclovir Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
11.3. Valganciclovir Market: By Application, 2022-2032, USD (Million)
11.4. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
11.5. Valganciclovir Market: By Region, 2022-2032, USD (Million)
11.5.1. Latin America
11.5.1.1. Brazil
11.5.1.1.1. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
11.5.1.1.2. Valganciclovir Market: By Application, 2022-2032, USD (Million)
11.5.1.1.3. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
11.5.1.2.2. Valganciclovir Market: By Application, 2022-2032, USD (Million)
11.5.1.2.3. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
11.5.1.3.2. Valganciclovir Market: By Application, 2022-2032, USD (Million)
11.5.1.3.3. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
12. Middle East and Africa Valganciclovir Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
12.3. Valganciclovir Market: By Application, 2022-2032, USD (Million)
12.4. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
12.5. Valganciclovir Market: By Region, 2022-2032, USD (Million)
12.5.1. Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
12.5.1.1.2. Valganciclovir Market: By Application, 2022-2032, USD (Million)
12.5.1.1.3. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
12.5.1.2.2. Valganciclovir Market: By Application, 2022-2032, USD (Million)
12.5.1.2.3. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Valganciclovir Market: By Patient Age Group, 2022-2032, USD (Million)
12.5.1.3.2. Valganciclovir Market: By Application, 2022-2032, USD (Million)
12.5.1.3.3. Valganciclovir Market: By Distribution Channel, 2022-2032, USD (Million)
13. Company Profiles
13.1. Roche
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. Gilead Sciences
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. Dr. Reddy's Laboratories
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Endo International plc
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. Cipla Limited
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Alniche Life Sciences Pvt. Ltd.
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. Anthem Biosciences Private Limited
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Merck & Co., Inc.
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Panacea Biotec Ltd.
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. Camber Pharmaceuticals, Inc.
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. Other Notable Players
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives
List of Figures
Figure 1 Global Valganciclovir Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Valganciclovir Market: Quality Assurance
Figure 5 Global Valganciclovir Market, By Patient Age Group, 2023
Figure 6 Global Valganciclovir Market, By Application, 2023
Figure 7 Global Valganciclovir Market, By Distribution Channel, 2023
Figure 8 Global Valganciclovir Market, By Geography, 2023
Figure 9 Market Geographical Opportunity Matrix - Global Valganciclovir Market, 2023
Figure 10 Market Positioning of Key Valganciclovir Market Players, 2023
Figure 11 Global Valganciclovir Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032
Figure 12 Global Valganciclovir Market, By Patient Age Group, 2023 Vs 2032, %
Figure 13 Global Valganciclovir Market, By Application, 2023 Vs 2032, %
Figure 14 Global Valganciclovir Market, By Distribution Channel, 2023 Vs 2032, %
Figure 15 U.S. Valganciclovir Market (US$ Million), 2022-2032
Figure 16 Canada Valganciclovir Market (US$ Million), 2022-2032
Figure 17 Rest of North America Valganciclovir Market (US$ Million), 2022-2032
Figure 18 UK Valganciclovir Market (US$ Million), 2022-2032
Figure 19 Germany Valganciclovir Market (US$ Million), 2022-2032
Figure 20 Spain Valganciclovir Market (US$ Million), 2022-2032
Figure 21 Italy Valganciclovir Market (US$ Million), 2022-2032
Figure 22 France Valganciclovir Market (US$ Million), 2022-2032
Figure 23 Rest of Europe Valganciclovir Market (US$ Million), 2022-2032
Figure 24 China Valganciclovir Market (US$ Million), 2022-2032
Figure 25 Japan Valganciclovir Market (US$ Million), 2022-2032
Figure 26 India Valganciclovir Market (US$ Million), 2022-2032
Figure 27 Australia Valganciclovir Market (US$ Million), 2022-2032
Figure 28 South Korea Valganciclovir Market (US$ Million), 2022-2032
Figure 29 Rest of Asia Valganciclovir Market (US$ Million), 2022-2032
Figure 30 Brazil Valganciclovir Market (US$ Million), 2022-2032
Figure 31 Mexico Valganciclovir Market (US$ Million), 2022-2032
Figure 32 Rest of Latin America Valganciclovir Market (US$ Million), 2022-2032
Figure 33 GCC Valganciclovir Market (US$ Million), 2022-2032
Figure 34 Africa Valganciclovir Market (US$ Million), 2022-2032
Figure 35 Rest of Middle East and Africa Valganciclovir Market (US$ Million), 2022-2032
List of Tables
Table 1 Global Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 2 Global Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 3 Global Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 4 North America Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 5 North America Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 6 North America Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 7 U.S. Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 8 U.S. Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 9 U.S. Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 10 Canada Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 11 Canada Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 12 Canada Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 13 Rest of North America Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 14 Rest of North America Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 15 Rest of North America Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 16 UK and European Union Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 17 UK and European Union Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 18 UK and European Union Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 19 UK Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 20 UK Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 21 UK Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 22 Germany Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 23 Germany Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 24 Germany Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 25 Spain Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 26 Spain Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 27 Spain Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 28 Italy Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 29 Italy Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 30 Italy Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 31 France Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 32 France Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 33 France Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 34 Rest of Europe Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 35 Rest of Europe Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 36 Rest of Europe Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 37 Asia Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 38 Asia Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 39 Asia Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 40 China Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 41 China Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 42 China Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 43 Japan Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 44 Japan Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 45 Japan Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 46 India Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 47 India Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 48 India Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 49 Australia Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 50 Australia Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 51 Australia Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 52 South Korea Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 53 South Korea Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 54 South Korea Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 55 Latin America Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 56 Latin America Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 57 Latin America Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 58 Brazil Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 59 Brazil Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 60 Brazil Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 61 Mexico Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 62 Mexico Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 63 Mexico Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 64 Rest of Latin America Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 65 Rest of Latin America Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 66 Rest of Latin America Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 67 Middle East and Africa Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 68 Middle East and Africa Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 69 Middle East and Africa Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 70 GCC Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 71 GCC Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 72 GCC Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 73 Africa Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 74 Africa Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 75 Africa Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)
Table 76 Rest of Middle East and Africa Valganciclovir Market By Patient Age Group, 2022-2032, USD (Million)
Table 77 Rest of Middle East and Africa Valganciclovir Market By Application, 2022-2032, USD (Million)
Table 78 Rest of Middle East and Africa Valganciclovir Market By Distribution Channel, 2022-2032, USD (Million)